The Affiliation of Most cancers Care Facilities (ACCC) has made accessible a brand new useful resource to help multidisciplinary most cancers care groups put together, implement, and consider digital well being document integrations for biomarker testing.
Biomarker testing has revolutionized most cancers remedy, offering details about a affected person’s distinctive most cancers, and permitting care groups to personalize remedy to raised tackle the affected person’s particular make-up. Oncology groups think about biomarker testing invaluable for saving extra lives. Nevertheless, integrating biomarker testing outcomes into the EHR may be burdensome. A survey performed in late 2023 by the American Society of Medical Oncology (ASCO) indicated that the “use of the digital well being document” was one of many prime two work stressors for oncologists in energetic observe – and the No. 1 ranked stressor indicated for these working at a non-academic establishment or observe.
“Integration of structured, discrete, searchable information factors can result in standardization of testing and simple retrieval of significant outcomes all whereas lowering the person supplier’s effort on a day-to-day foundation. EHR integration and information administration of biomarkers is nothing wanting transformative,” stated Jennifer Johnson, M.D., Ph.D., in a press release. An ACCC member, Johnson is co-director of the Sidney Kimmel Most cancers Heart Precision Medication Initiative, and affiliate professor on the Division of Medical Oncology and Division of Otolaryngology at Thomas Jefferson College Well being System.
The EHR Roadmap is an interactive instrument designed to assist oncology professionals study important data to determine the muse for EHR integration and descriptions methods for staff preparation, guiding efficient implementation and analysis processes. The EHR Roadmap features a useful resource library with instruments, checklists, publications, and insights from a number of most cancers facilities, giving most cancers groups the assets to simplify EHR integrations into their practices, particularly for biomarker ordering and reporting.
Its instruments have been developed based mostly on outcomes from the ACCC Working Summit: Options for EHR Integration, facilitated by ACCC within the fall of 2023. At that assembly, multidisciplinary oncology professionals gathered to debate challenges to EHR integration and laid the groundwork for the EHR Roadmap.
Karen Huelsman, M.S., L.G.C., an ACCC member and precision oncology lead and genetic counselor at TriHealth Most cancers and Blood Institute, who offered a case examine on the Summit, noticed how wide-ranging most cancers facilities have been in implementation.
“In the course of the Summit, we observed that there have been many facilities on various components of the method, some have been very early on feeling annoyed with EHR integration, and a few completely different facilities have been halfway, the place they’d began implementation, however had run into some obstacles that have been stalling the method,” she stated. “Different facilities had already absolutely carried out their EHR and have been already utilizing energetic and dwell ordering and ensuing methods. On the very forefront have been facilities that have been already constructing reviews that use discrete variants and exhibiting the uptake of utilization by their ordering suppliers.”
The roadmap was created in partnership with LUNGevity and with help from AstraZeneca and Genentech.
